个人笔录。免责!查看全文
chuminhua2019-09-07 15:11
9/5,Zafgen的MetAP2抑制剂ZGN-1061因为安全性问题临床研究被FDA暂停。现在该公司希望能够寻找买家来帮助它脱离困境。该公司还有一个临床前药物ZGN-1258。消息传出后,Zafgen股价下跌14%,期股价降至每股0.70美元左右。$Zafgen(ZFGN)$查看全文
美股魔方2019-05-31 17:49
$Zafgen(ZFGN)$ 昨天跟FDA会议,FDA仍然认为依照现有数据,没有办法排除ZGN-1061会出现类似公司之前另一个药beloranib的心血管安全性风险,现在让ZFGN回去进行动物实验来排除这种风险查看全文
越炒股越美2019-03-13 14:57
【3月13日医药股跌幅盘点】制药公司 Zafgen 治疗代谢紊乱新药申请暂停,跌幅超37%。$Zafgen(ZFGN)$ $Tonix医药控股(TNXP)$ $Matinas Biopharma(MTNB)$ 3月13日跌幅最大的医药股分别是:制药公司Zafgen下跌37.17%;制药公司Tonix Pharmaceuticals Holding Corp. 下跌11.87%;生物制药公司Matinas Bi...查看全文
淘沙见金2017-10-05 12:06
(Rhythm Pharmaceuticals$Rhythm Pharmaceuticals Inc(RYTM)$ 明天即将IPO,这里简单的介绍一下,不足之处请读者见谅)
Rhythm Pharmaceutical成立于 2008年, 依靠的是从Ipsen授权的两个肽产品药物。Rhythm Pharmaceutical利用其中一个药物成立了Motus Therapeutics,并于2016年以$200 million...查看全文
$Zafgen, Inc.(ZFGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-12 AccNo: 0001104659-18-008108 Size: 52 KB 网页链接
$Zafgen, Inc.(ZFGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-12 AccNo: 0001104659-18-008108 Size: 52 KB 网页链接
$Zafgen, Inc.(ZFGN)$ 8-K - Current report Filed: 2018-01-05 AccNo: 0001193125-18-004559 Size: 304 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registran...
$Zafgen, Inc.(ZFGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-07 AccNo: 0001193125-17-335910 Size: 2 MB 网页链接
$Zafgen, Inc.(ZFGN)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001193125-17-335861 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Zafgen, Inc.(ZFGN)$ CORRESP [Cover] - Correspondence Filed: 2017-08-21 AccNo: 0001193125-17-263712 Size: 9 KB 网页链接
$Zafgen, Inc.(ZFGN)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-08-14 AccNo: 0000000000-17-028702 Size: 130 KB 网页链接
$Zafgen, Inc.(ZFGN)$ 内部交易: 2017-10-13,Director,Heller Frances K ,买入,10000普通股, $3.90
$Zafgen, Inc.(ZFGN)$ 8-K - Current report Filed: 2017-10-12 AccNo: 0001193125-17-308904 Size: 142 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Other Eve...
$Zafgen, Inc.(ZFGN)$ EFFECT - Notice of Effectiveness Filed: 2017-08-23 AccNo: 9999999995-17-002187 Size: 1 KB 网页链接